Sorin Group Italia S.R.L.: FDA filings under this applicant name
FDA lists 63 510(k) clearances under the applicant name “Sorin Group Italia S.R.L.” (first 1995, latest 2026), across 10 product codes in 2 review panels. Median 510(k) review time under this name: 76 days. Since 2017 the median was 104 days, against 125 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
Caduvo groups this applicant name under LivaNova, based on public ownership records.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 7 | 90 |
| 2013 | 3 | 27 |
| 2014 | 1 | 17 |
| 2015 | 2 | 120 |
| 2016 | 0 | — |
| 2017 | 2 | 285 |
| 2018 | 3 | 30 |
| 2019 | 2 | 86 |
| 2020 | 3 | 88 |
| 2021 | 1 | 60 |
| 2022 | 0 | — |
| 2023 | 2 | 191 |
| 2024 | 5 | 86 |
| 2025 | 5 | 129 |
| 2026 | 3 | 70 |
Review time against the same product codes
Since 2017, 510(k)s cleared under the name Sorin Group Italia S.R.L. took a median 104 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 125 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| DTZ | Oxygenator, Cardiopulmonary Bypass | 22 | 22 |
| DWF | Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass | 14 | 14 |
| DTN | Reservoir, Blood, Cardiopulmonary Bypass | 8 | 8 |
| CAC | Apparatus, Autotransfusion | 6 | 6 |
| DTM | Filter, Blood, Cardiopulmonary Bypass, Arterial Line | 6 | 6 |
| KDI | Dialyzer, High Permeability With Or Without Sealed Dialysate System | 2 | 2 |
| KRH | Ring, Annuloplasty | 2 | 2 |
| DRE | Dilator, Vessel, For Percutaneous Catheterization | 1 | 1 |
| DTR | Heat-Exchanger, Cardiopulmonary Bypass | 1 | 1 |
| KFM | Pump, Blood, Cardiopulmonary Bypass, Non-Roller Type | 1 | 1 |
Review panels
Most recent Sorin Group Italia S.R.L. 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K263092 | Dual Stage Venous Cannulae | DWF | 2026-10-01 | 28 |
| K262052 | Tri Stage Venous Cannulae | DWF | 2026-09-28 | 102 |
| K253671 | Dual Stage Venous Cannulae | DWF | 2026-01-30 | 70 |
| K251783 | Inspire HCR and HCR DUAL cardiotomy reservoirs | DTN | 2025-12-22 | 194 |
| K253616 | ProtekDilate Vascular Access Kit | DRE | 2025-12-19 | 31 |
| K250610 | Easyflow (103-200; 103-300); Easyflow Duo (103-210; 103-310) | DWF | 2025-06-27 | 119 |
| K250150 | VANGUARD Blood cardioplegia Systems (Vanguard 4:1 Blood cardioplegia set); VANGUARD Blood cardioplegia Systems (Vanguard 4:1 Blood cardioplegia set with shunt); VANGUARD Blood cardioplegia Systems (Vanguard 4:1 Blood Cardioplegia Set Mini) | DTR | 2025-05-30 | 129 |
| K243264 | DHF 0.2 Hemoconcentrator (DHF 02); DHF 0.6 Hemoconcentrator (DHF 06); SH 14 Hemoconcentrator (SH 14) | KDI | 2025-04-25 | 192 |
| K242953 | KIDS Arterial Filters | DTM | 2024-12-20 | 86 |
| K242092 | MICRO Arterial Filters | DTM | 2024-11-18 | 124 |
53 earlier clearances. See the full list in Caduvo.
Recalls
6 product recalls in 2 recall events; 0 initiated in the last five years. Most recent: 2020-07-29.
11 product recalls in 6 recall events filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 0 initiated in the last five years. Most often: Sorin Group USA, Inc. (9), LivaNova USA (2).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Parent company SEC filings
LivaNova PLC (LIVN): EDGAR filings, CIK 1639691. Caduvo groups Sorin Group Italia S.R.L. under LivaNova; the parent's SEC registrant is entered by hand for the group, not matched by name.
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- Sorin Biomedica, Fiat, USA, Inc. (20 510(k)s)
- Sorin Group Deutschland GmbH (20 510(k)s)
- Sorin Biomedical, Inc. (15 510(k)s)
- Sorin Group USA, Inc. (2 510(k)s)
- Sorin Biomedica Cardio S.R.L. (1 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Sorin Group Italia S.R.L.?
FDA lists 63 510(k) clearances under the applicant name “Sorin Group Italia S.R.L.” (first 1995, latest 2026), across 10 product codes in 2 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Sorin Group Italia S.R.L.?
The median time from FDA receipt to decision across 510(k)s cleared under the name Sorin Group Italia S.R.L. is 76 days. Since 2017: 104 days, versus 125 days for all cleared 510(k)s in the same product codes.
Which FDA product codes appear under Sorin Group Italia S.R.L.?
The most frequent FDA product codes under this applicant name are DTZ (Oxygenator, Cardiopulmonary Bypass, 22); DWF (Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass, 14); DTN (Reservoir, Blood, Cardiopulmonary Bypass, 8).
Next steps
- See all 63 Sorin Group Italia S.R.L. clearances with predicates and recalls
- Run predicate analysis for product code DTZ, Sorin Group Italia S.R.L.'s most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant name shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.